💾 Archived View for gmi.noulin.net › mobileNews › 4978.gmi captured on 2022-07-16 at 15:18:05. Gemini links have been rewritten to link to archived content

View Raw

More Information

⬅️ Previous capture (2021-12-03)

➡️ Next capture (2023-01-29)

-=-=-=-=-=-=-

US health watchdog cracks down on antibacterial soaps

A woman washes her hands with antibacterial soap in a September 2009 file photo

Scientists warn antibacterial products may create resistance to antibiotics in

humans (file photo)

The US health regulator has warned that antibacterial chemicals in soaps and

body washes may pose health risks.

The Food and Drug Administration (FDA) called for a safety review of such

products.

It proposed a rule requiring manufacturers to prove such soaps are safe and

more effective against infection than plain soap and water.

Recent studies indicate an ingredient in such products could scramble hormone

levels and boost drug-proof bacteria.

The proposal rule does not apply to alcohol-based hand sanitizers and products

used in healthcare settings.

Manufacturers have until the end of 2014 to submit the results of clinical

trials on their products, the FDA said. The new regulations would be finalised

in 2016.

'Unanticipated hormonal effects'

"New data suggest that the risks associated with long-term, daily use of

antibacterial soaps may outweigh the benefits," Colleen Rogers, an FDA

microbiologist, wrote in a statement on Monday.

Certain ingredients in such products - such as triclosan in liquid soaps and

triclocarban in bar soaps - may contribute to bacterial resistance to

antibiotics, the agency added.

Such products may also have "unanticipated hormonal effects that are of

concern", according to the statement.

Recent studies of such chemicals on animals have shown they may alter hormones,

the FDA said, but such results have not yet been proven in humans.

"Because so many consumers use them, FDA believes that there should be clearly

demonstrated benefits to balance any potential risks," the statement added.

If the FDA's proposed rule is finalised, companies would be required to provide

data to support their product's health claims.

If they cannot, the products would be reformulated or relabelled in order to

remain on the market.

In March, a federal appeals court approved a lawsuit by the non-profit Natural

Resources Defense Council, aimed at forcing the FDA to review the health

impacts of triclosan.